MicroRNA | Liver disease | Target gene(s) |
---|---|---|
miR-155 | Protective role against non alcoholic steatosis [33] | |
Up-regulated in NASH [34] | ||
Up-regulated in HCC [35] | ||
MiR-155 deficiency attenuates steatosis and fibrosis [36] | ||
miR-193b | Down-regulated in HBV+ HCC [43] | CCND1, ETS1 [43] |
NF1 (HNSCC) [46] | ||
Smad3 (glioma) [47] | ||
miR-20a | Down-regulated in HCC [49] | Mcl-1 [49] |
miR-200a | Up-regulated in NAFLD [51] | ZEB1, ZEB2 [54] |
Down-regulated in HCC [52] | ||
miR-200c | Up-regulated in NAFLD [51] | ZEB1, ZEB2, NCAM1 [54] |
Down-regulated in HCC and ICC [54] | ||
miR-27a | Up-regulated in HBV+ HCC [55] | |
miR-31 | Up-regulated in fibrosis [60] | FIH1 [60] |
miR-93 | PTEN, CDKN1A [62] | |
miR-99b | Up-regulated in HCC [69] | mTOR (pancreatic cancer) [66] |
CLDN11 [69] | ||
miR-125a-5p | Down-regulated in HCC [89] | SIRT7 [89] |
Biomarker in liver disease [93] | ||
miR-182 | Up-regulated in NAFLD-fibrosis [98] | FOXO3 [98] |